Cargando…
Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
Autor principal: | Healthcare Engineering, Journal of |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432048/ https://www.ncbi.nlm.nih.gov/pubmed/37593493 http://dx.doi.org/10.1155/2023/9823939 |
Ejemplares similares
-
Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
por: Li, Linzhang, et al.
Publicado: (2022) -
Retracted: Regulatory Networks of Prognostic mRNAs in Pediatric Acute Myeloid Leukemia
por: Healthcare Engineering, Journal of
Publicado: (2022) -
Retracted: Inhibition of microRNA-665 Alleviates Septic Acute Kidney Injury by Targeting Bcl-2
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retracted: Hyperleukocytic Acute Leukemia Circulating Exosomes Regulate HSCs and BM-MSCs
por: Healthcare Engineering, Journal of
Publicado: (2022) -
Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
por: Healthcare Engineering, Journal of
Publicado: (2023)